Epidemiology and burden of illness of rheumatoid arthritis

No abstract is available for this paper.

• Publication year

  2012

• Venue

  PharmacoEconomics (Auckland)

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.2165/00019053-200422001-00002PMID 15157000
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Review of the Direct Costs of Rheumatoid Arthritis

  2012influential reference
• The Burden of Arthritis and Nonsteroidal Anti-Inflammatory Treatment

  2012influential reference
• The Underestimated Long Term Medical and Economic Consequences of Rheumatoid Arthritis

  2012cited by this paper
• Rheumatoid arthritis in women. Incidence rates in group health cooperative, Seattle, Washington, 1987-1989.

  2010cited by this paper
• Clinical arthritis associated with positive radiological and serological findings in Finnish adults

  2004cited by this paper
• Influence of disease-modifying therapy on radiographic outcome in inflammatory polyarthritis at five years: results from a large observational inception study.

  2003cited by this paper
• Disease activity and health status in rheumatoid arthritis: a case-control comparison between Norway and Lithuania

  2003cited by this paper
• The impact of functional status and change in functional status on mortality over 18 years among persons with rheumatoid arthritis.

  2002cited by this paper
• Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis.

  2002cited by this paper
• Modeling the progression of rheumatoid arthritis: a two-country model to estimate costs and consequences of rheumatoid arthritis.

  2002influential reference
• Which patients stop working because of rheumatoid arthritis? Results of five years' follow up in 732 patients from the Early RA Study (ERAS)

  2002cited by this paper
• Preferences for improved health examined in 1,024 patients with rheumatoid arthritis: pain has highest priority.

  2002cited by this paper
• Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period.

  2002cited by this paper
• Economic and quality-of-life impact of rheumatoid arthritis.

  2001cited by this paper
• Total Mortality is Increased in Rheumatoid Arthritis. A 17-Year Prospective Study

  2001cited by this paper
• Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies.

  2001cited by this paper
• Indirect medical costs in early rheumatoid arthritis: composition of and changes in indirect costs within the first three years of disease.

  2001cited by this paper
• History of affective disorder and the temporal trajectory of fatigue in rheumatoid arthritis

  2001cited by this paper
• The course of depression in recent onset rheumatoid arthritis: the predictive role of disability, illness perceptions, pain and coping.

  2001cited by this paper
• Mortality in rheumatoid arthritis: relationship to single and composite measures of disease activity.

  2001cited by this paper
• Economic and quality-of-life impact of rheumatoid arthritis.

  2001cited by this paper
• Reduced disability at five years with early treatment of inflammatory polyarthritis: results from a large observational cohort, using propensity models to adjust for disease severity.

  2001cited by this paper
• Incidence and prevalence of rheumatoid arthritis in the county of Troms, northern Norway.

  2000cited by this paper
• The disproportionate impact of chronic arthralgia and arthritis among women.

  2000cited by this paper
• Direct and indirect costs of rheumatoid arthritis to an employer.

  2000cited by this paper
• Economic burden of rheumatoid arthritis: a systematic review.

  2000cited by this paper
• Direct and indirect costs associated with the onset of seropositive rheumatoid arthritis. Western Consortium of Practicing Rheumatologists.

  2000cited by this paper
• The burden of rheumatoid arthritis. Based on a presentation by Frederick Wolfe, MD.

  1999cited by this paper
• Changes in the incidence and prevalence of rheumatoid arthritis in Kamitonda, Wakayama, Japan, 1965–1996

  1999cited by this paper
• Estimating the incidence of rheumatoid arthritis: trying to hit a moving target?

  1999cited by this paper
• An assessment of the annual and long-term direct costs of rheumatoid arthritis: the impact of poor function and functional decline.

  1999influential reference
• The epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955-1985.

  1999cited by this paper
• Work disability in rheumatoid arthritis 10 years after the diagnosis.

  1999cited by this paper
• Economic consequences of the progression of rheumatoid arthritis in Sweden.

  1999influential reference
• Mortality in rheumatoid arthritis: have we made an impact in 4 decades?

  1999cited by this paper
• Modeling the lifetime costs of rheumatoid arthritis.

  1999cited by this paper
• The Burden of Rheumatoid Arthritis

  1999cited by this paper
• Early effective suppression of inflammation in rheumatoid arthritis reduces radiographic progression.

  1998cited by this paper
• Epidemiology of rheumatoid arthritis in Finland.

  1998cited by this paper
• Fatigue in rheumatoid arthritis: the role of self-efficacy and problematic social support.

  1998cited by this paper
• Prevalence of rheumatoid arthritis in circumpolar native populations.

  1998cited by this paper
• Longterm mortality outcome in patients with rheumatoid arthritis: early presenters continue to do well.

  1998cited by this paper
• The incidence and severity of rheumatoid arthritis, results from a county register in Oslo, Norway.

  1998cited by this paper
• [Epidemiology of rheumatoid arthritis in Finland].

  1998cited by this paper
• Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States.

  1998cited by this paper
• Effects of rheumatoid arthritis on employment and social participation during the first years of disease in The Netherlands.

  1998influential reference
• Direct cost of rheumatoid arthritis during the first six years: a cost-of-illness study.

  1998cited by this paper
• The relationship between psychological distress and traditional clinical variables: a 2 year prospective study of 216 patients with early rheumatoid arthritis.

  1997cited by this paper
• Direct medical costs unique to people with arthritis.

  1997cited by this paper
• Indirect and nonmedical costs among people with rheumatoid arthritis and osteoarthritis compared with nonarthritic controls.

  1997cited by this paper
• Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden.

  1997cited by this paper
• The prevalence and severity of rheumatoid arthritis in Oslo. Results from a county register and a population survey.

  1997influential reference
• Increase in age at onset of rheumatoid arthritis in Japan over a 30 year period

  1997cited by this paper
• Epidemiological and clinical aspects relating to the variability of rheumatoid arthritis.

  1997influential reference
• Epidemiology and estimated population burden of selected autoimmune diseases in the United States.

  1997cited by this paper
• Resource utilization and cost of care for rheumatoid arthritis and osteoarthritis in a managed care setting: the importance of drug and surgery costs.

  1997cited by this paper
• Direct and indirect medical costs incurred by Canadian patients with rheumatoid arthritis: a 12 year study.

  1997cited by this paper
• The cost of rheumatoid arthritis.

  1996cited by this paper
• The prevalence and meaning of fatigue in rheumatic disease.

  1996cited by this paper
• Correlates of functional disability in early rheumatoid arthritis: a cross-sectional study of 706 patients in four European countries.

  1996cited by this paper
• Shift in the incidence of rheumatoid arthritis toward elderly patients in Finland during 1975-1990.

  1996cited by this paper
• Risk factors for depression in rheumatoid arthritis.

  1996cited by this paper
• The costs of rheumatoid arthritis: absolute, incremental, and marginal estimates.

  1996cited by this paper
• Incidence of rheumatoid arthritis in Finland during 1980-1990.

  1996cited by this paper
• The Effectiveness of Early Treatment with Second-Line Antirheumatic Drugs

  1996cited by this paper
• The impact of early rheumatoid arthritis on psychological distress. A comparison between 238 patients with RA and 116 matched controls.

  1996cited by this paper
• Differences in symptom reports between men and women with rheumatoid arthritis.

  1996cited by this paper
• Comparison of self-reported fatigue in rheumatoid arthritis and controls.

  1995cited by this paper
• Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5 year followup of a prospective double blind placebo controlled study.

  1995cited by this paper
• Shortening of life span and causes of excess mortality in a population-based series of subjects with rheumatoid arthritis.

  1995cited by this paper
• The incidence of rheumatoid arthritis in the United Kingdom: results from the Norfolk Arthritis Register.

  1994cited by this paper
• The Costs of Rheumatoid Arthritis

  1994influential reference
• The mortality of rheumatoid arthritis.

  1994cited by this paper
• [A panorama of rheumatic diseases].

  1994cited by this paper
• Decreasing incidence and prevalence of rheumatoid arthritis in Pima Indians over a twenty-five-year period.

  1994influential reference
• Low incidence of rheumatoid arthritis in France.

  1994cited by this paper
• Breast-feeding and the onset of rheumatoid arthritis.

  1993cited by this paper
• Hormonal pattern in women affected by rheumatoid arthritis

  1993cited by this paper
• Correlates of Fatigue in Older Adults with Rheumatoid Arthritis

  1993cited by this paper
• Incidence of rheumatoid arthritis in central Massachusetts.

  1993cited by this paper
• Depressed levels of dehydroepiandrosterone sulphate in postmenopausal women with rheumatoid arthritis but no relation with axial bone density.

  1993cited by this paper
• Rheumatoid arthritis, the contraceptive pill, and androgens.

  1993cited by this paper
• Locomotion status and costs in destructive rheumatoid arthritis. A comprehensive study of 82 patients from a population of 13,000.

  1992cited by this paper
• High prevalence of rheumatoid arthritis ra among north american native indians nani support for the new world theory of ra

  1991influential reference
• Rheumatic diseases in Alaskan Indians of the southeast coast: high prevalence of rheumatoid arthritis and systemic lupus erythematosus.

  1991cited by this paper
• Changes in the incidence and prevalence of rheumatoid arthritis in England and Wales, 1970-1982.

  1990cited by this paper
• Reduction of the risk of rheumatoid arthritis among women who take oral contraceptives.

  1990influential reference
• Revised criteria for the classification of rheumatoid arthritis.

  1990cited by this paper
• High incidence and prevalence of rheumatoid arthritis in Pima Indians.

  1989cited by this paper
• The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

  1988cited by this paper
• Mortality in rheumatoid arthritis.

  1988influential reference
• Survival, prognosis, and causes of death in rheumatoid arthritis.

  1986cited by this paper
• A multicenter study of hospitalization in rheumatoid arthritis: effect of health care system, severity, and regional difference.

  1986cited by this paper
• A multicenter study of annual health service utilization and costs in rheumatoid arthritis.

  1986cited by this paper
• Prevalence and social impact of rheumatic diseases in Finland.

  1983cited by this paper
• Prevalence and social impact of rheumatic diseases in Finland.

  1983cited by this paper
• The impact of chronic disease

  1981cited by this paper
• The impact of chronic disease: a sociomedical profile of rheumatoid arthritis.

  1981cited by this paper
• The epidemiology of rheumatoid arthritis in Rochester, Minnesota: a study of incidence, prevalence, and mortality.

  1980cited by this paper
• The costs of rheumatoid arthritis. A patient-oriented study of chronic disease costs.

  1978cited by this paper

• Experimental Investigation and PC-SAFT Modeling of Etodolac Solubility in Deep Eutectic Solvents and Aqueous Solutions

  2026cites this paper
• When poverty gets into your joints: exploring socioeconomic, environmental, and gendered determinants of rheumatoid arthritis in district Dir lower, Pakistan

  2026cites this paper
• Structural model of body image and personality traits: The mediating role of emotion regulation in rheumatoid arthritis

  2025cites this paper
• Calciphylaxis: A Mimic of Vasculitis

  2025cites this paper
• Extra Virgin Olive Oil Polyphenol-Enriched Extracts Exert Antioxidant and Anti-Inflammatory Effects on Peripheral Blood Mononuclear Cells from Rheumatoid Arthritis Patients

  2025influential citation
• Efficacy of pharmacological interventions and therapeutic exercises for rheumatoid arthritis: a systematic review and meta-analysis

  2025cites this paper
• Dyslipidemia and Its Association with Accelerated Atherosclerosis in Rheumatoid Arthritis Patients: A Cross-Sectional Study

  2025cites this paper
• Lower Heart Rate Variability is Associated with High Disease Activity, Functional Disability and Inflammation in Rheumatoid Arthritis: A Cross-Sectional Study

  2025cites this paper
• A Prospective Evaluation of Tocilizumab in Patients With Rheumatoid Arthritis Refractory to Conventional Disease-Modifying Anti-Rheumatic Medications (DMARDs)

  2025cites this paper
• Dissolving microneedles: A transdermal drug delivery system for the treatment of rheumatoid arthritis.

  2025cites this paper
• Pharmacokinetic distinctions between small molecules and biologics in treating rheumatoid arthritis: implications for personalized therapeutic strategies and formulation development

  2025influential citation
• Disease knowledge and quality of life among rheumatoid arthritis patients: a cross-sectional study

  2025cites this paper
• Assessment of Cardiac Risk Factors and Socio Demographic Feature of Rheumatoid Arthritis in Bangladesh

  2025cites this paper
• Work productivity and activity impairment in patients with rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis: a comparative analysis from the POLNOR-Rheuma cohort

  2025cites this paper
• Trends in stroke occurrence in rheumatoid arthritis: a retrospective cohort study from Western Norway, 1972 through 2020

  2025cites this paper
• The natural course of health-related quality of life in patients with clinically suspect arthralgia: a longitudinal study in progressors and non-progressors to rheumatoid arthritis

  2025cites this paper
• Comparison of Opioid Utilization in Older Adults with Rheumatoid Arthritis before and after Initiating Biological or Targeted Synthetic Disease-Modifying Antirheumatic Drugs.

  2025cites this paper
• Comparison of the clinical efficacy and pharmacoeconomics of tofacitinib and adalimumab in Chinese patients with rheumatoid arthritis: An analysis based on propensity score matching

  2025cites this paper
• Comparison of anti-IL-6 receptor and JAK inhibitors in patients with rheumatoid arthritis from the real-world practice FIRST study.

  2024cites this paper
• CT informs detection and treatment options in rheumatoid arthritis complicated by pulmonary non-tuberculous mycobacterial disease from the FIRST registry

  2024cites this paper
• Tocilizumab Reduces Depression Risk in Rheumatoid Arthritis Patients: A Systematic Review and Meta-Analysis

  2024cites this paper
• Exploration and validation of therapeutic molecules for rheumatoid arthritis based on ferroptosis-related genes.

  2024cites this paper
• Advancing rheumatic disease treatment: A journey towards better lives

  2024cites this paper
• Relation between iron deficiency anemia and Rheumatoid Arthritis

  2023cites this paper
• Spectrum of and Factors Associated with Eye Disorders among Rheumatoid Arthritis Patients Attending Tertiary Hospital in Uganda

  2023cites this paper
• Double-negative-2 B cells are the major synovial plasma cell precursor in rheumatoid arthritis

  2023cites this paper
• The global magnitude and temporal trend of rheumatoid arthritis burden attributable to smoking from 1990 to 2019.

  2023cites this paper
• A comprehensive analysis of rheumatoid arthritis B cells reveals the importance of CD11c+ve double-negative-2 B cells as the major synovial plasma cell precursor

  2023cites this paper
• Signaling pathways in rheumatoid arthritis: implications for targeted therapy

  2023cites this paper
• VHPKQHR Peptide Modified Ultrasmall Paramagnetic Iron Oxide Nanoparticles Targeting Rheumatoid Arthritis for T1-Weighted Magnetic Resonance Imaging

  2022influential citation
• Journey from Serendipity to Biologics

  2022cites this paper
• Tailoring Tofacitinib Oral Therapy in Rheumatoid Arthritis: The TuTOR App

  2022cites this paper
• The economic burden of biologic disease-modifying antirheumatic drugs in rheumatoid arthritis patients in the United States

  2022cites this paper
• 20S-Hydroxyvitamin D3, a Secosteroid Produced in Humans, Is Anti-Inflammatory and Inhibits Murine Autoimmune Arthritis

  2021cites this paper
• Efficacy and safety of tofacitinib versus baricitinib in patients with rheumatoid arthritis in real clinical practice: analyses with propensity score-based inverse probability of treatment weighting

  2021cites this paper
• The accuracy of administrative health data for identifying patients with rheumatoid arthritis: a retrospective validation study using medical records in Western Australia

  2021cites this paper
• Frequency of Prescription Claims for Drugs that May Interact with Janus Kinase Inhibitors Among Patients with Rheumatoid Arthritis in the US

  2021cites this paper
• Serum TNFα levels at 24 h after certolizumab pegol predict effectiveness at week 12 in patients with rheumatoid arthritis from TSUBAME study

  2021cites this paper
• Golimumab: A novel human anti-TNF-alpha monoclonal antibody Golimumab: A novel human anti-TNF-alpha monoclonal antibody for the treatment of rheumatoid arthritis, ankylosing spondylitis, for the treatment of rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis and psoriatic arthriti

  2021cites this paper
• OARRR_A_322833 239..246

  2021cites this paper
• Effectiveness of biologics and targeted synthetic disease‐modifying anti‐rheumatic drugs in conjunction with methotrexate for the treatment of early rheumatoid arthritis: A systematic review of randomized controlled trials

  2021cites this paper
• The Role of Glucocorticoids in Inflammatory Diseases

  2021cites this paper
• A Crowdsourcing Approach to Develop Machine Learning Models to Quantify Radiographic Joint Damage in Rheumatoid Arthritis

  2021cites this paper
• The impact of diabetes mellitus on treatment and outcomes of rheumatoid arthritis at 5-year follow-up: results from a multi-ethnic Asian cohort

  2021cites this paper
• Two Sides of the Same Coin? A Dual Multiple Criteria Decision Analysis of Novel Treatments Against Rheumatoid Arthritis in Physicians and Patients.

  2021cites this paper
• Impact of socio-demographic and clinical characteristics on functional disability and health-related quality of life in patients with rheumatoid arthritis: a cross-sectional study from Palestine

  2021cites this paper
• Patterns of Response to Different Treatment Strategies in Seropositive Rheumatoid Arthritis Patients in a Tertiary Hospital in South‐Western Saudi Arabia: A Retrospective Study

  2021cites this paper
• Association Between Janus Kinase Inhibitors Therapy and Mental Health Outcome in Rheumatoid Arthritis: A Systematic Review and Meta-analysis

  2021cites this paper
• Autoinjector – A smart device for emergency cum personal therapy

  2021cites this paper
• Clinical, Patient-Reported, and Ultrasound Outcomes from an Open-Label, 12-week Observational Study of Certolizumab Pegol in Spanish Patients with Rheumatoid Arthritis with or without Prior Anti-TNF Exposure.

  2020influential citation
• Validity of Self-reported Diagnosis of Rheumatoid Arthritis

  2020cites this paper
• Association of MICA-129Met/Val polymorphism with clinical outcome of anti-TNF therapy and MICA serum levels in patients with rheumatoid arthritis

  2020cites this paper
• High times for painful blues: the endocannabinoid system in pain-depression comorbidity Running title: Cannabinoids in pain-depression interactions

  2020cites this paper
• Joint Diseases 2

  2020cites this paper
• Rheumatoid arthritis : a joint venture

  2020cites this paper
• The associations between executive functions and different aspects of perceived pain, beyond the influence of depression, in rehabilitation setting

  2020cites this paper
• The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review

  2020cites this paper
• Small Molecule Inhibitors in the Treatment of Rheumatoid Arthritis and Beyond: Latest Updates and Potential Strategy for Fighting COVID-19

  2020cites this paper
• Predicting treatment response to IL6R blockers in rheumatoid arthritis

  2020cites this paper
• Adiposity and the risk of rheumatoid arthritis: a systematic review and meta-analysis of cohort studies

  2020cites this paper
• Prevalence of rheumatoid arthritis among hospital workers in the north of Jordan: Preliminary report of a hospital-based cohort study

  2020cites this paper
• Comparative Cost per Response for 4 Clinical Endpoints with Tocilizumab Monotherapy vs Adalimumab Monotherapy in a Head-to-Head Randomized Double-Blind Superiority Trial (ADACTA) in Patients with Rheumatoid Arthritis

  2020cites this paper
• Comorbidities in rheumatoid arthritis: the RBSMR study

  2020cites this paper
• Individual, community and societal burden following acute hand and wrist injury

  2020cites this paper
• Comparative evaluation of efficacy, pharmacodynamics, and safety of Hetero’s adalimumab (Mabura®, Hetero Biopharma Ltd.) and reference adalimumab (Humira®, Abbvie Inc.) in patients with active rheumatoid arthritis on concomitant methotrexate therapy

  2020cites this paper
• Fatherhood Experiences of Men With Inflammatory Arthritis: A Preliminary Grounded Theory

  2020cites this paper
• Arthritis flare after stopping TNF inhibitor in RA: frequency, predictability and radiography

  2020cites this paper
• Clinical Utility and Cost Savings in Predicting Inadequate Response to Anti-TNF Therapies in Rheumatoid Arthritis

  2020cites this paper
• Lifetime Risks, Life Expectancy, and Health Care Expenditures for Rheumatoid Arthritis: A Nationwide Cohort Followed Up From 2003 to 2016

  2020cites this paper
• Prevalence, Indirect Costs, and Risk Factors for Work Disability in Patients with Crohn’s Disease at a Tertiary Care Center in Rio de Janeiro

  2020cites this paper
• Identifying Rheumatoid Arthritis Cases within the Quebec Health Administrative Database

  2019cites this paper
• Cost evolution of biological drugs in rheumatoid arthritis patients in a tertiary hospital: Influential factors on price.

  2019cites this paper
• TOAST: improving reference-free cell composition estimation by cross-cell type differential analysis

  2019cites this paper
• Radiographic Progression and Histopathologic Correlation of Adjuvant Arthritis Ameliorated by Boswellia serrata

  2019influential citation
• Comparative risk of malignancies and infections in patients with rheumatoid arthritis initiating abatacept versus other biologics: a multi-database real-world study

  2019cites this paper
• Anti‐inflammatory and antioxidative properties of honey bee venom on Freund's Complete Adjuvant‐induced arthritis model in rats

  2019cites this paper
• Tai Chi for rheumatoid arthritis.

  2019cites this paper
• Cost-minimization analysis of biological disease-modifying antirheumatic drugs in the Brazilian public health system (SUS) considering patients’ weight

  2019influential citation
• Assessing disease severity in bio-naïve patients with RA on treatment with csDMARDs: insights from the Corrona Registry

  2019cites this paper
• Subclinical atherosclerosis and endothelial dysfunction in patients with polymyalgia rheumatica: a pilot study

  2019cites this paper
• Secular trends of sustained remission in rheumatoid arthritis, a nationwide study in Sweden.

  2019cites this paper
• Longterm, Real-world Safety of Adalimumab in Rheumatoid Arthritis: Analysis of a Prospective US-based Registry

  2019cites this paper
• Biologics: A tectonic shift in the management of rheumatoid arthritis

  2019cites this paper
• Monotherapy is a relevant option in rheumatoid arthritis treatment: a literature review.

  2019cites this paper
• Application of GC/MS-Based Metabonomic Profiling in Studying the Therapeutic Effects of Aconitum carmichaeli with Ampelopsis japonica Extract on Collagen-Induced Arthritis in Rats

  2019cites this paper
• Nonopioid versus opioid agents for chronic neuropathic pain, rheumatoid arthritis pain, cancer pain and low back pain.

  2019cites this paper
• Perturbation of the human gut microbiome by a non-antibiotic drug contributes to the resolution of autoimmune disease

  2019cites this paper
• Lipid profile in arthritides

  2019influential citation
• Prevalence of sustained remission in rheumatoid arthritis: impact of criteria sets and disease duration, a Nationwide Study in Sweden

  2019cites this paper
• Orthopedic Surgery in Rheumatoid Arthritis: Results from the Spanish National Registry of Hospitalized Patients over 17 Years

  2019cites this paper
• A Bayesian mixed treatment comparison of efficacy of biologics and small molecules in early rheumatoid arthritis

  2019cites this paper
• Sustained discontinuation of infliximab with a raising-dose strategy after obtaining remission in patients with rheumatoid arthritis: the RRRR study, a randomised controlled trial

  2019cites this paper
• Review of Biosimilar Trials and Data on Adalimumab in Rheumatoid Arthritis

  2018cites this paper
• One-year risk of serious infection in patients treated with certolizumab pegol as compared with other TNF inhibitors in a real-world setting: data from a national U.S. rheumatoid arthritis registry

  2018cites this paper
• The role of self-efficacy in pain intensity, function, psychological factors, health behaviors, and quality of life in people with rheumatoid arthritis: A systematic review

  2018cites this paper
• Drugs for the Management of Rheumatoid Arthritis: Clinical Evaluation

  2018cites this paper
• Trends in hip fracture in patients with rheumatoid arthritis: results from the Spanish National Inpatient Registry over a 17-year period (1999–2015). TREND-AR study

  2018cites this paper
• The Impact of Targeted Rheumatoid Arthritis Pharmacologic Treatment on Mental Health

  2018cites this paper
• Multi-biomarker disease activity score as a predictor of disease relapse in patients with rheumatoid arthritis stopping TNF inhibitor treatment

  2018cites this paper
• Quality of Care in Rheumatoid Disease from the Clinician Perspective: A Modified Delphi Panel Approach

  2018cites this paper